Akrivia BioSciences

Akrivia BioSciences is a pioneering innovator dedicated to revolutionizing cancer diagnostics and precision medicine. Based in Mumbai, Maharashtra, Akrivia BioSciences focuses on developing groundbreaking technologies that deliver next-generation diagnostic tests, enabling optimal and personalized treatment strategies for various cancers. These tests are uniquely designed to be both predictive and prognostic, facilitating a significant reduction in overtreatments and leading to enhanced treatment responses. With a commitment to precision, Akrivia BioSciences is poised to reshape the landscape of cancer care. The company’s primary address is F301 Kailash Industrial Complex, Hiranandani Link Road, Vikhroli (W), Mumbai, Maharashtra 400079, IN. Akrivia BioSciences is focused on continuing to innovate in the health and human services industry, improving patient outcomes through advanced diagnostics.

Akrivia BioSciences’ core innovation lies in its novel technologies that provide unparalleled insights into cancer progression. These tests are designed to assist clinicians in tailoring treatment plans with greater accuracy, maximizing efficacy while minimizing unnecessary interventions. The commitment to patient-centric care is central to Akrivia BioSciences’ mission, striving to provide tools that empower both medical professionals and individuals navigating the challenges of cancer.

Looking ahead, Akrivia BioSciences is dedicated to expanding its portfolio of innovative diagnostic solutions and solidifying its position as a leader in precision oncology. Driven by a team of experienced professionals, the company is poised for significant growth and impact in the health and human services sector. Akrivia BioSciences welcomes the opportunity to discuss future collaborations and product listings on our platform. We encourage you to create a customized and exclusive company showcase to further highlight your advancements.